<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Case Rep</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1752-1947</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25928714</article-id>
      <article-id pub-id-type="pmc">4422471</article-id>
      <article-id pub-id-type="publisher-id">570</article-id>
      <article-id pub-id-type="doi">10.1186/s13256-015-0570-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Efficacy of aerobic physical retraining in a case of combined pulmonary fibrosis and emphysema syndrome: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>De Simone</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <address>
            <email>sparcs@libero.it</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aquino</surname>
            <given-names>Giovanna</given-names>
          </name>
          <address>
            <email>giovanna.aquino@unimol.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Di Gioia</surname>
            <given-names>Claudio</given-names>
          </name>
          <address>
            <email>claudio.digioia@casadicuravillamargherita.it</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mazzarella</surname>
            <given-names>Gennaro</given-names>
          </name>
          <address>
            <email>gennaro.mazzarella@unina2.it</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Bianco</surname>
            <given-names>Andrea</given-names>
          </name>
          <address>
            <email>andrea.bianco@unimol.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Calcagno</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <address>
            <email>giuseppe.calcagno@unimol.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Medicine and Health Sciences, &#x201C;V Tiberio&#x201D; University of Molise, Campobasso, Italy </aff>
        <aff id="Aff2"><label/>Institute of Rehabilitation &#x201C;Villa Margherita Benevento&#x201D;, Unit of Cardiology and Pneumology, Benevento, Italy </aff>
        <aff id="Aff3"><label/>Department of Cardio-Thoracic and Respiratory Sciences, Second University of Napoli, Napoli, Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>85</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; De Simone et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Introduction</title>
          <p>Combined pulmonary fibrosis and emphysema has recently been recognized as a syndrome but remains under-diagnosed. Neither clinical management nor therapeutic approaches have been clearly defined. Pulmonary rehabilitation has not been considered within the therapeutic options for combined pulmonary fibrosis and emphysema. In this case we explored the potential benefits of a specific aerobic physical retraining program in the management of combined pulmonary fibrosis and emphysema.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We describe the case of a 65-year-old Caucasian man with combined pulmonary fibrosis and emphysema and respiratory failure who was receiving long-term oxygen therapy. Our patient underwent physical retraining with moderate intensity aerobic and breathing exercises for four weeks. Clinical and motor tests, as well as questionnaires assessing quality of life and depression levels, were performed prior to and following the retraining. At the end of the retraining program a relevant reduction of long-term oxygen therapy requirement was registered; improvements in terms of physical performance, quality of life, and mood were observed in our patient but no change in respiratory parameters.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>A program of aerobic physical retraining appears to be beneficial to patients with combined pulmonary fibrosis and emphysema and may be considered as an additional therapeutic option.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Aerobic physical retraining</kwd>
        <kwd>Combined pulmonary fibrosis and emphysema</kwd>
        <kwd>CPFE</kwd>
        <kwd>Pulmonary rehabilitation</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>High-resolution computed tomography (HRCT) scanning has enhanced recognition of the simultaneous occurrence of emphysema and pulmonary fibrosis and, recently, combined pulmonary fibrosis and emphysema (CPFE) has been defined as a syndrome. This syndrome is characterized by upper lobe emphysema and lower lobe fibrosis [<xref ref-type="bibr" rid="CR1">1</xref>]. Common risk factors resulting in epithelial lung alterations may contribute to emphysema and pulmonary fibrosis despite clinical, radiological, and pathologic differences [<xref ref-type="bibr" rid="CR2">2</xref>-<xref ref-type="bibr" rid="CR4">4</xref>]. Coexistence of emphysema and fibrosis are more likely to occur in smoking-induced parenchymal pulmonary damage [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>]. CPFE is still under-diagnosed and clinical management as well as therapeutic approaches have not yet been clearly defined. In this case we explore the potential benefits of a specific aerobic physical retraining program, which has not yet been considered within the therapeutic options for CPFE.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>We report the case of a 65-year-old Caucasian man who had previously smoked cigarettes (40 pack-years) who had CPFE with several comorbidities, including hypertension, type II diabetes, and depression. Before his CPFE diagnosis our patient had been affected by chronic bronchitis for 12 years. His diagnosis of CPFE was confirmed by thoracic HRCT showing areas of intralobular interstitial and septal thickening with peripheral bilateral distribution in addition to centrilobular emphysema of both his upper lobes. On admission to our rehabilitation clinic, our patient exhibited chronic respiratory failure, reporting dyspnea on exertion and productive cough; our patient was receiving long-term oxygen therapy (LTOT) with 2.5L/min of flow during 24 hours as his peripheral capillary oxygen saturation (SpO<sub>2</sub>) steeply declined when oxygen therapy was discontinued (SpO<sub>2</sub>= 84%). Spirometry showed a relatively mild restriction although his diffusion lung capacity for carbon monoxide (DLCO) was 44% of predicted. Concurrent pulmonary hypertension (PAP 60mmHg) was diagnosed by color doppler echocardiography.</p>
      <p>Our patient&#x2019;s pharmacological therapy consisted of high dose inhaled steroids, acetyl-cysteine 1200mg once daily, angiotensin-converting-enzyme inhibitor (Lisinopril) 10mg once daily, and aspirin 100mg once daily. Respiratory and physical exercise test assessments were carried out at admission and discharge; in addition, quality of life (St. George Respiratory) and depression level (Geriatric Depression Scale) questionnaires were administered by a clinical psychologist. Our patient performed the six-minute walk test (6MWT) to evaluate his aerobic physical performance according to the European Respiratory Society/American Thoracic Society recommendation, 2014. The test was performed by an exercise physiologist indoors, along a long, flat, straight, enclosed corridor with a hard surface of 30 meters, and results reported as distance (meters) covered in six minutes. His usual medical regimen was continued and oxygen therapy during the test was administered via a portable oxygen tank. As required by standard protocol, our patient decided the speed of the walk, stopping as required and resuming the test when recovered. Before, during, and after the test, his heart rate and oxygen saturation were reordered using a professional oximeter, and dyspnea levels and overall fatigue were assessed according to the Borg Scale and Visual Analogue Scale (VAS) before and immediately after exercise test. After two weeks in our rehabilitation unit, our patient was clinically stabilized and enrolled in the retraining program for four weeks. The retraining program took place in the cardiorespiratory gymnasium of our rehabilitation unit. Written consent was obtained from our patient before starting the exercise program.</p>
      <p>Each retraining session was supervised by an exercise physiologist monitoring heart and respiratory rate, oxygen saturation, blood pressure, and level of dyspnea. Our patient underwent the exercise program for two sessions per day up to 30 minutes each, five days per week, for a four-week period. The training included one session of aerobic exercise and one session of breathing technique. For aerobic training, he exercised on a treadmill, with a speed of 2.5km per hour and 0% of slope. The intensity of aerobic exercise was adapted to our patient&#x2019;s functional capacity on the basis of his 6MWT results, in accordance with aerobic exercise intensity recommended by American Thoracic Society Guidelines 2006 for pulmonary rehabilitation. Therefore, the work rate of training corresponded to 50% to 60% of his maximum heart rate and the training began at a work rate equal to 50%. When our patient reached the level of exercise at 10 minutes without intolerable dyspnea (Borg rating of breathlessness of &lt;5), the workload (speed and/or elevation) and duration of exercise were increased by 10% [<xref ref-type="bibr" rid="CR7">7</xref>]. Progressive exercise training was employed for his respiratory muscles; the training consisted of diaphragmatic breathing and inspiratory muscle training, through an inspiratory threshold, at 40% to 50% of his initial maximal inspiratory pressure (PiMax). During training our patient received oxygen therapy to maintain SpO<sub>2</sub> &gt;92%; a flow reduction of 15% was made each week.</p>
      <p>After the four-week retraining program, because his arterial blood gas analysis showed a PaO<sub>2</sub> increase of 11% and PCO<sub>2</sub> decrease of 5.6% on oxygen with a flow of 2.5L/min, it was possible to reduce his LTOT to a flow of 1.5L/min for 24 hours to compensate hypoxemia. The oxygen requirement reduction observed may have been due to the strengthening of his respiratory muscles, which allowed improvement of his exercise capacity [<xref ref-type="bibr" rid="CR8">8</xref>]. His pulmonary artery systolic pressure, estimated by transthoracic two-dimensional echocardiography, improved by 16% in terms of cardiac index and pulmonary vascular resistance [<xref ref-type="bibr" rid="CR9">9</xref>]; no significant lung function changes were observed. Relevant improvements in exercise capacity, dyspnea rating, health-related quality of life, and levels of depression were also demonstrated after the pulmonary rehabilitation program. His 6MWT showed an increase of distance walked by 133%. His dyspnea scores were reduced: the level of dyspnea at rest (the Modified Medical Research Council Dyspnea Scale) decreased from 3.0 to 2.0, Borg Scale during exercise was reduced from 9.0 to 5.0, and his post-exercise VAS decreased from 8.0 to 5.0; there was only a minor increase in PiMax of 17%. Our patient&#x2019;s adherence to the retraining program was good and no adverse events occurred. Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref> reports the test results collected before and after the retraining program.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Results of cardiorespiratory and clinical tests before and after a retraining program in a patient with combined pulmonary fibrosis and emphysema</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Test</bold>
</th><th colspan="2">
<bold>Assessment before retraining program</bold>
</th><th colspan="2">
<bold>Assessment after retraining program</bold>
</th></tr></thead><tbody><tr valign="top"><td>Respiratory functional tests</td><td>FEV1/FVC</td><td>
<bold>78%</bold>
</td><td>FEV1/FVC</td><td>
<bold>77%</bold>
</td></tr><tr valign="top"><td rowspan="2"> &#x2022; Spirometry</td><td>FEV1</td><td>
<bold>79%</bold> of predicted value</td><td>FEV1</td><td>
<bold>82%</bold> of predicted value</td></tr><tr valign="top"><td>FVC</td><td>
<bold>73%</bold> of predicted value</td><td>FVC</td><td>
<bold>75%</bold> of predicted value</td></tr><tr valign="top"><td> &#x2022; Diffusion lung capacity for carbon monoxide</td><td>DLCO</td><td>
<bold>44%</bold> of predicted value</td><td>DLCO</td><td>
<bold>47%</bold> of predicted value</td></tr><tr valign="top"><td/><td>PaO<sub>2</sub>
</td><td>
<bold>63.4</bold>mmHg</td><td>PaO<sub>2</sub>
</td><td>
<bold>70.4</bold>mmHg</td></tr><tr valign="top"><td>Arterial blood gas analysis</td><td>PaCO<sub>2</sub>
</td><td>
<bold>35.6</bold>mmHg</td><td>PaCO<sub>2</sub>
</td><td>
<bold>33.6</bold>mmHg</td></tr><tr valign="top"><td>on oxygen 2.5L/min</td><td>pH</td><td>
<bold>7.46</bold>
</td><td>pH</td><td>
<bold>7.369</bold>
</td></tr><tr valign="top"><td>Dyspnea scales</td><td/><td/><td/><td/></tr><tr valign="top"><td> &#x2022; Modified Medical Research Council</td><td/><td>
<bold>3.0</bold>
</td><td/><td>
<bold>2.0</bold>
</td></tr><tr valign="top"><td> &#x2022; Visual Analogue Scale</td><td/><td>
<bold>8.0</bold>
</td><td/><td>
<bold>5.0</bold>
</td></tr><tr valign="top"><td> &#x2022; Borg Scale</td><td/><td>
<bold>9.0</bold>
</td><td/><td>
<bold>5.0</bold>
</td></tr><tr valign="top"><td rowspan="2">Transthoracic two-dimensional echocardiography</td><td>PAP</td><td>
<bold>60</bold>mmHg</td><td>PAP</td><td>
<bold>50</bold>mmHg</td></tr><tr valign="top"><td>Right ventricular hypertrophy</td><td/><td>Right ventricular hypertrophy</td><td/></tr><tr valign="top"><td>Physical exercise test</td><td/><td/><td/><td/></tr><tr valign="top"><td rowspan="2"> &#x2022; Respiratory muscle strength</td><td>PiMax</td><td>
<bold>40</bold>mmHg</td><td>PiMax</td><td>
<bold>53</bold>mmHg</td></tr><tr valign="top"><td>PeMax</td><td>
<bold>25</bold>mmHg</td><td>PeMax</td><td>
<bold>60</bold>mmHg</td></tr><tr valign="top"><td>Six-minute walk test</td><td/><td>
<bold>90</bold>m<sup>a</sup>
</td><td/><td>
<bold>210</bold>m</td></tr><tr valign="top"><td>Geriatric Depression Scale</td><td/><td>
<bold>25/30</bold> severe depression</td><td/><td>
<bold>16/30</bold> mild depression</td></tr><tr valign="top"><td/><td>Symptoms</td><td>
<bold>77.51</bold>
</td><td>Symptoms</td><td>
<bold>50.18</bold>
</td></tr><tr valign="top"><td>Quality of life</td><td>Physical activities</td><td>
<bold>85.66</bold>
</td><td>Physical activities</td><td>
<bold>62.55</bold>
</td></tr><tr valign="top"><td rowspan="2">St. George Questionnaire</td><td>Impact</td><td>
<bold>70.39</bold>
</td><td>Impact</td><td>
<bold>50.64</bold>
</td></tr><tr valign="top"><td>Total score</td><td>
<bold>83.86</bold>
</td><td>Total score</td><td>
<bold>71.54</bold>
</td></tr><tr valign="top"><td>Long-term oxygen therapy</td><td>Flow 2.5L/min for 24 hours</td><td/><td>Flow 1.5L/min for 24 hours</td><td/></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>The six-minute walk test, before the retraining program, was stopped due to patient breathlessness. DLCO, diffusion lung capacity for carbon monoxide; FEV 1, Forced expiratory volume in one second; FVC, forced vital capacity; PaO<sub>2</sub>, partial arterial pressure of oxygen; PaCO<sub>2</sub>, partial pressure of carbon dioxide; PAP, pulmonary artery pressure; PiMax, maximal inspiratory pressure; PeMax, maximal expiratory pressure.</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>In this case study we evaluated whether a patient with CPFE, a disease which has not yet been considered for pulmonary rehabilitation, can benefit from an aerobic retraining program. Emphysema and pulmonary fibrosis are progressive lung diseases that may be associated with comorbidities and systemic consequences [<xref ref-type="bibr" rid="CR10">10</xref>-<xref ref-type="bibr" rid="CR14">14</xref>]. CPFE syndrome typically occurs in male smokers and is frequently complicated by pulmonary hypertension, acute lung injury, and lung cancer, which affect disease progression and survival. In the literature there are no reports on the efficacy of physical retraining in patients with CPFE, in contrast with other lung diseases such as chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis where clinical studies have demonstrated the benefits of pulmonary rehabilitation [<xref ref-type="bibr" rid="CR15">15</xref>]. Clinically relevant improvements and short-term benefits were clearly demonstrated in this report as a result of a retraining program. Although clinical studies on long-term effects within a large patient population are required for definitive conclusions, our observations suggest that integrating pulmonary rehabilitation with pharmacological treatments would be beneficial for patients with CPFE.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>In the literature there are no reports on the effects of pulmonary rehabilitation in patients with CPFE. The potential efficacy of aerobic exercise on quality of life and psychological well-being and exercise capacity function in a patient with CPFE has been demonstrated in this case. Our results suggest that exercise should also be considered as a therapeutic option for patients with CPFE, although further studies considering the impact of different types of training in this patient population are required.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>DLCO</term>
          <def>
            <p>diffusion lung capacity for carbon monoxide</p>
          </def>
        </def-item>
        <def-item>
          <term>FEV 1</term>
          <def>
            <p>Forced Expiratory Volume in one second</p>
          </def>
        </def-item>
        <def-item>
          <term>FVC</term>
          <def>
            <p>Forced Vital Capacity</p>
          </def>
        </def-item>
        <def-item>
          <term>HRCT</term>
          <def>
            <p>high-resolution computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>LTOT</term>
          <def>
            <p>long-term oxygen therapy</p>
          </def>
        </def-item>
        <def-item>
          <term>PaO<sub>2</sub></term>
          <def>
            <p>partial arterial pressure of oxygen</p>
          </def>
        </def-item>
        <def-item>
          <term>PaCO<sub>2</sub></term>
          <def>
            <p>partial pressure of carbon dioxide</p>
          </def>
        </def-item>
        <def-item>
          <term>PAP</term>
          <def>
            <p>pulmonary artery pressure</p>
          </def>
        </def-item>
        <def-item>
          <term>PiMax</term>
          <def>
            <p>maximal inspiratory pressure</p>
          </def>
        </def-item>
        <def-item>
          <term>PeMax</term>
          <def>
            <p>maximal expiratory pressure</p>
          </def>
        </def-item>
        <def-item>
          <term>6MWT</term>
          <def>
            <p>six-minute walk test, VAS, Visual Analogue Scale</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>GDS, GM, AB, and GC analyzed and interpreted the patient data and wrote the article. GDS, GA, and CDG planned and carried out the pulmonary rehabilitation program. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cottin</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brillet</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity</article-title>
          <source>Eur Respir J.</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>586</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1183/09031936.05.00021005</pub-id>
          <pub-id pub-id-type="pmid">16204587</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chilosi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Poletti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The pathogenesis of COPD and IPF: distinct horns of the same devil?</article-title>
          <source>Respir Res.</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>3</fpage>
          <pub-id pub-id-type="doi">10.1186/1465-9921-13-3</pub-id>
          <pub-id pub-id-type="pmid">22235752</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazzarella</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Esposito</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory effects on human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM1.0) and pollen allergens</article-title>
          <source>Environ Pollut.</source>
          <year>2012</year>
          <volume>161</volume>
          <fpage>64</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.envpol.2011.09.046</pub-id>
          <pub-id pub-id-type="pmid">22230069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Esposito</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lucariello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Savarese</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM1.0) and pollen allergens</article-title>
          <source>Environ Pollut.</source>
          <year>2012</year>
          <volume>171</volume>
          <fpage>162</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.envpol.2012.07.006</pub-id>
          <pub-id pub-id-type="pmid">22922455</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katzenstein</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Mukhopadhyay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zanardi</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Clinically occult interstitial fibrosis in smokers: classification significance of a surprisingly common finding in lobectomy specimens</article-title>
          <source>Hum Pathol</source>
          <year>2010</year>
          <volume>41</volume>
          <issue>3</issue>
          <fpage>316</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2009.09.003</pub-id>
          <pub-id pub-id-type="pmid">20004953</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Laurentiis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Paris</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Melck</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate</article-title>
          <source>J Proteome Res.</source>
          <year>2013</year>
          <volume>12</volume>
          <fpage>1502</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1021/pr301171p</pub-id>
          <pub-id pub-id-type="pmid">23360153</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maldor</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kufel</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Pineda</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Effect of pulmonary rehabilitation on quadriceps fatigability during exercise</article-title>
          <source>Am J Respir Crit Care Med.</source>
          <year>2001</year>
          <volume>163</volume>
          <fpage>930</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1164/ajrccm.163.4.2006125</pub-id>
          <pub-id pub-id-type="pmid">11282768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Decramer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Response of the respiratory muscles to rehabilitation in COPD</article-title>
          <source>J Appl Physiol.</source>
          <year>2009</year>
          <volume>107</volume>
          <fpage>971</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1152/japplphysiol.91459.2008</pub-id>
          <pub-id pub-id-type="pmid">19342436</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mereles</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ehlken</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kreuscher</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension</article-title>
          <source>Circulation.</source>
          <year>2006</year>
          <volume>114</volume>
          <fpage>1482</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.618397</pub-id>
          <pub-id pub-id-type="pmid">16982941</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daniele</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Rosa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nigro</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease</article-title>
          <source>Int J Biochem Cell Biol.</source>
          <year>2012</year>
          <volume>44</volume>
          <fpage>563</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biocel.2011.12.016</pub-id>
          <pub-id pub-id-type="pmid">22233975</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nigro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Scudiero</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Sarnataro</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Adiponectin affects lung epithelial A549 cell viability counteracting TNFa and IL-1&#xDF; toxicity through AdipoR1</article-title>
          <source>Int J Biochem Cell Biol</source>
          <year>2013</year>
          <volume>45</volume>
          <issue>6</issue>
          <fpage>1145</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biocel.2013.03.003</pub-id>
          <pub-id pub-id-type="pmid">23500159</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corbi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Turchiarelli</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on sirtuins</article-title>
          <source>Int J Mol Sci</source>
          <year>2013</year>
          <volume>14</volume>
          <issue>6</issue>
          <fpage>12696</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.3390/ijms140612696</pub-id>
          <pub-id pub-id-type="pmid">23774840</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bianco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mazzarella</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Turchiarelli</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Adiponectin: an attractive marker for metabolic disorders in chronic obstructive pulmonary disease (COPD)</article-title>
          <source>Nutrients.</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>4115</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.3390/nu5104115</pub-id>
          <pub-id pub-id-type="pmid">24128974</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nussbaumer-Ochsner</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rabe</surname>
              <given-names>KF</given-names>
            </name>
          </person-group>
          <article-title>Systemic manifestations of COPD</article-title>
          <source>Chest.</source>
          <year>2011</year>
          <volume>139</volume>
          <fpage>165</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.10-1252</pub-id>
          <pub-id pub-id-type="pmid">21208876</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kozu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Senjyu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease</article-title>
          <source>Respiration</source>
          <year>2010</year>
          <volume>81</volume>
          <issue>3</issue>
          <fpage>196</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="doi">10.1159/000315475</pub-id>
          <pub-id pub-id-type="pmid">20516666</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
